Gene Panel Market is expected to Grow at CAGRof 7.45% Through 2030F
Increasing incidence of cancer is
expected to drive the growth of global gene panel in the forecast period 2026-2030F
According to TechSci Research report, “Gene
Panel Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2020-2030F”, Global Gene Panel Market was valued at USD 2.98 billion in 2024 and is expected to reach USD 4.55 billion by 2030 with a CAGR of 7.45% during the forecast period. This can
be ascribed to the increasing technological advancements in genomics such as
NGS technology and increasing adoption rate of genetic testing. The growing
demand for prenatal diagnosis and increasing awareness about advantages of
using gene panel technique, instead of conventional method, is expected to
create lucrative opportunities for the market growth in coming years. Besides,
growing initiatives in population sequencing by the government and rising
investments by major key players to develop a new technology, are further
expected to support the market growth.
However, inability of next generation sequencing gene
panels in detecting some allelic mutations and growing concerns about genetic
data security, lack of accuracy and standardization in diagnostic tests may
hamper the market growth.
Browse over XX market data Figures
spread through XX Pages and an in-depth
TOC on "Gene Panel Market"
The Global Gene Panel Market
can be segmented by component, by technique, by end user and by region.
Based on End User, Hospitals and diagnostic
laboratories are the leading end users in the global gene panel market due to
their central role in delivering comprehensive diagnostic services and
personalized treatment. These facilities are equipped with advanced
infrastructure and specialized personnel, including pathologists, genetic
counselors, and molecular biologists, enabling them to efficiently conduct
complex genetic testing such as gene panel analysis. Hospitals often serve as
the primary point of care, where patients first present symptoms and require
accurate and timely diagnosis to guide treatment decisions. Gene panels,
especially those targeting oncology, cardiovascular, and rare genetic
disorders, are increasingly integrated into clinical workflows in hospital settings
to support precision medicine. Diagnostic laboratories, on the other hand,
specialize in high-throughput testing and often partner with hospitals and
clinics to provide outsourced genetic testing services. These labs utilize
next-generation sequencing (NGS) platforms and bioinformatics tools to deliver
accurate, large-scale gene panel analyses. As demand for genetic testing
grows—driven by rising awareness, increased incidence of genetic diseases, and
advancements in NGS technologies—both hospitals and diagnostic labs are
expanding their capabilities. Their established infrastructure, access to a
broad patient base, and ability to interpret and act on complex genomic data
position hospitals and diagnostic laboratories as the dominant end-user segment
in the gene panel market.
Based on region, Asia-Pacific is the fastest-growing
region in the global gene panel market due to several key factors. Rapid
improvements in healthcare infrastructure, rising awareness of genetic
disorders, and increased government investment in genomics and precision medicine
are driving regional growth. Countries like China, India, Japan, and South
Korea are witnessing a surge in demand for advanced diagnostic tools, fueled by
a growing burden of chronic and genetic diseases. The availability of a large
patient population, lower costs for conducting clinical research, and expanding
medical tourism further contribute to the region’s momentum. The emergence of
local biotech firms, collaborations with global players, and increasing
adoption of next-generation sequencing technologies are accelerating innovation
and accessibility. Supportive regulatory reforms and strategic initiatives by
governments to promote genomic testing and personalized healthcare are also
enhancing market potential. These combined factors make Asia-Pacific a hotspot
for growth in the gene panel industry.
Major companies operating in global
gene panel market are:
·
Illumina, Inc.
·
Agilent Technologies, Inc.
·
Thermo Fischer Scientific, Inc.
·
QIAGEN NV
·
Eurofins Scientific SE
·
Foundation Medicine Inc.
·
Guardant Health, Inc.
·
Myriad Genetic Laboratories Inc.
·
Bio-Rad Laboratories, Inc.
·
F. Hoffmann-La Roche AG
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“Asia Pacific was expected to dominate and register
the highest growth in the global gene panel market on account of increasing
demand for safe and effective genetic tests in the region. The increasing
demand for personalized medicine is expected to support the market growth in
the region in the coming years. In addition, the growing application of genetic
testing in oncology is further expected to fuel the market growth in the coming
years. The growing healthcare spending is one of the major factors responsible
for creating lucrative opportunities for the market growth” said Mr. Karan
Chechi, Research Director of TechSci Research, a research based global
management consulting firm.
“Gene Panel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Test Kits v/s Testing Services), By Technique (Amplicon Based Approach v/s Hybridization Based Approach), By End User (Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), By Region and Competition, 2020-2030F”, has evaluated the future
growth potential of global gene panel market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global gene panel market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com